dpp-4 inhibitors

Cutting Potassium Risk: A Breakthrough for Diabetes Patients High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

Cutting Potassium Risk: A Breakthrough for Diabetes Patients

Contributor September 23, 2024

This population-based cohort study investigates the relationship between the use of SGLT-2 inhibitors, GLP-1 receptor agonists, and...

Discover the Powerful Link Between Diabetes and Dementia Prevention A medical study scene showing two types of diabetes medication (SGLT-2 inhibitors vs. DPP-4 inhibitors) influencing brain health. The image should depict brain protection, neurons, and a futuristic approach to dementia prevention. Clear elements of healthcare, diabetes, and cognitive science.